Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Pharmacotherapy. 2015 May 23;35(6):569–577. doi: 10.1002/phar.1591

Table 4.

Multivariate Modeling Output for Intrapatient Tacrolimus Trajectory for Acute Rejection and Interstitial Fibrosis/ Tubular Atrophy, Stratified by Race

Outcomea Cohort Parameter estimate Standard error Adjusted HR 95% CI p value
Acute rejectionb African-American 2.81 0.42 16.60 7.3–37.9 < 0.0001
Non–African-American 1.54 0.30 4.65 2.58–8.36 < 0.0001
IF/TAc African-American 2.07 1.81 7.91 0.23–275.3 0.2534
Non–African-American −1.21 3.89 0.30 0.00–609.3 0.7560

CI = confidence interval; HLA = human leukocyte antigen; HR = hazard ratio; IF/TA = interstitial fibrosis/tubular atrophy.

a

Model adjusted for gender, age, diabetes, insurance, donor type, HLA mismatch, panel reactive antibody, retransplant, and induction.

b

Interaction term p=0.0003.

c

Interaction term p=0.1823.